Oncotelic Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $11.8M | $474.0K |
| FY2021 | — | $8.0M | $568.8K |
| FY2022 | — | $19.4M | $241.5K |
| FY2023 | — | $12.1M | $170.4K |
| FY2024 | — | $8.3M | — |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $11.8M | $474.0K |
| FY2021 | — | $8.0M | $568.8K |
| FY2022 | — | $19.4M | $241.5K |
| FY2023 | — | $12.1M | $170.4K |
| FY2024 | — | $8.3M | — |